MedTrace Logo

Reducing Depression and Anxiety Among Teens

NCT06155838 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2025-02-03

No results posted yet for this study

Summary

The objective of this clinical trial is to assess the efficacy of the Early Adolescent Skills for Emotions (EASE) program, a school-based, non-specialist psychosocial intervention developed by the WHO for LMICs, in alleviating Anxiety and Depression among teens aged 13-19. The primary inquiries it seeks to address include:

Does the EASE intervention effectively reduce anxiety and depression scores 12 weeks after implementation?

* Can the EASE intervention enhance quality of life, improve problem-solving skills, and increase perceived emotional support?
* Is the EASE intervention beneficial for enhancing the psychological well-being of parents and fostering positive parent-teen relationships?

Conditions

Interventions

OTHER

"Early Adolescent Skills for Emotions (EASE)

Weekly Schedule for Teen's and their parents Sessions: Over the course of 7 sessions, with one session per week lasting 90 minutes, the following core components will be covered: Week 1: Exploring My Feelings Week 2: Learning to Calm Week 3 \& 4: Learning CBT- Restructuring My Thinking, Changing Feelings and My Actions \& Managing My Emotions and Issues Week 5 \& 6: Fostering Independent Problem-Solving Skills and Seeking Help Week 7: Relapse Prevention 2.0 For parents/ guardians Week 3 Psychoeducation (to develop skills to be able to identify, listen, better respond and provide comfort to teens when they are overwhelmed by anxiety and depression). Week 4 Positive parenting strategies Week 5 Parents/ guardians Self-care

Sponsors & Collaborators

  • Shandong University

    collaborator OTHER

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Lubna Ghazal · Aga Khan University

  • Coa Fenglin · Shandong University - China

  • Cui Naixue · Shandong University - China

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-27
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06155838 on ClinicalTrials.gov